Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gaussian curvature-driven direction of cell fate toward osteogenesis with triply periodic minimal surface scaffolds. | Proc Natl Acad Sci U S A | 2022 | 36191194 | PubTator, text mining | PubMed |
| Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma. | Front Immunol | 2022 | 36189255 | PubTator, text mining | PubMed |
| Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription. | PLoS Pathog | 2022 | 36174106 | PubTator, text mining | PubMed |
| Time and age dependent regulation of neuroinflammation in a rat model of mesial temporal lobe epilepsy: Correlation with human data. | Front Cell Dev Biol | 2022 | 36172274 | PubTator, text mining | PubMed |
| The role of protein acetylation in carcinogenesis and targeted drug discovery. | Front Endocrinol (Lausanne) | 2022 | 36171897 | PubTator, text mining | PubMed |
| Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma. | Front Oncol | 2022 | 36158685 | PubTator, text mining | PubMed |
| MLK3 Regulates Inflammatory Response via Activation of AP-1 Pathway in HEK293 and RAW264.7 Cells. | Int J Mol Sci | 2022 | 36142785 | PubTator, text mining | PubMed |
| Inflammation: Roles in Skeletal Muscle Atrophy. | Antioxidants (Basel) | 2022 | 36139760 | PubTator, text mining | PubMed |
| Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors. | Cells | 2022 | 36139434 | PubTator, text mining | PubMed |
| Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical Probes. | J Med Chem | 2022 | 36136092 | PubTator, text mining | PubMed |
| Exploring the Mechanism of Realgar against Esophageal Cancer Based on Ferroptosis Induced by ROS-ASK1-p38 MAPK Signaling Pathway. | Evid Based Complement Alternat Med | 2022 | 36133791 | PubTator, text mining | PubMed |
| SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p. | Cancer Biol Ther | 2022 | 36131361 | PubTator, text mining | PubMed |
| Deep RNA sequencing of intensive care unit patients with COVID-19. | Sci Rep | 2022 | 36130991 | PubTator, text mining | PubMed |
| Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers. | Front Oncol | 2022 | 36119484 | PubTator, text mining | PubMed |
| The Response of the Human Umbilical Vein Endothelial Cell Transcriptome to Variation in Magnesium Concentration. | Nutrients | 2022 | 36079843 | PubTator, text mining | PubMed |
| Construction, bioinformatics analysis, and validation of competitive endogenous RNA networks in ulcerative colitis. | Front Genet | 2022 | 36061211 | PubTator, text mining | PubMed |
| Stellera chamaejasme L. extracts in the treatment of glioblastoma cell lines: Biological verification based on a network pharmacology approach. | Front Oncol | 2022 | 36059675 | PubTator, text mining | PubMed |
| Identification of ceRNA regulatory network in acute pancreatitis and acute recurrent pancreatitis. | Eur J Gastroenterol Hepatol | 2022 | 36052691 | PubTator, text mining | PubMed |
| Erythrocyte mitogen-activated protein kinases mediate hemolytic events under osmotic and oxidative stress and in hemolytic diseases. | Cell Signal | 2022 | 36029940 | PubTator, text mining | PubMed |
| Flaviviridae Nonstructural Proteins: The Role in Molecular Mechanisms of Triggering Inflammation. | Viruses | 2022 | 36016430 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=14